Sigilon Therapeutics’ stock soars 550% after Eli Lilly agrees to acquire company
June 29, 2023 at 10:06 AM EDT
Deal is focused on new cell therapies to improve diabetes care.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|